Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circadian system disorder induced by aberrantly activated EFNB2-EPHB2 axis leads to facilitated liver metastasis in gastric cancer. | Cell Oncol (Dordr) | 2024 | 39298082 | PubTator, text mining | PubMed |
| Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics. | Sci Rep | 2024 | 39085301 | PubTator, text mining | PubMed |
| pH-Responsive Biocompatible Fluorescent Hydrogel for Selective Sensing and Adsorptive Recovery of Dysprosium. | ACS Omega | 2024 | 39005826 | PubTator, text mining | PubMed |
| Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity. | Cell Commun Signal | 2024 | 38811954 | PubTator, text mining | PubMed |
| Click Chemistry: Reaction Rates and Their Suitability for Biomedical Applications. | Bioconjug Chem | 2024 | 38775705 | PubTator, text mining | PubMed |
| Alzheimer's diseases in America, Europe, and Asian regions: a global genetic variation. | PeerJ | 2024 | 38756443 | PubTator, text mining | PubMed |
| Integrated proteomic, phosphoproteomic, and N-glycoproteomic analyses of small extracellular vesicles from C2C12 myoblasts identify specific PTM patterns in ligand-receptor interactions. | Cell Commun Signal | 2024 | 38755675 | PubTator, text mining | PubMed |
| Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations. | J Transl Med | 2024 | 38750573 | PubTator, text mining | PubMed |
| Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology. | Proc Natl Acad Sci U S A | 2024 | 38701119 | PubTator, text mining | PubMed |
| Quiescent Adult Neural Stem Cells: Developmental Origin and Regulatory Mechanisms. | Neurosci Bull | 2024 | 38656419 | PubTator, text mining | PubMed |
| Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets. | Front Oncol | 2024 | 38651144 | PubTator, text mining | PubMed |
| Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway. | J Cancer Res Clin Oncol | 2024 | 38630320 | PubTator, text mining | PubMed |
| The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies. | Int J Mol Sci | 2024 | 38612645 | PubTator, text mining | PubMed |
| EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis. | Arthritis Rheumatol | 2024 | 38589317 | PubTator, text mining | PubMed |
| Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy. | ACS Omega | 2024 | 38496987 | PubTator, text mining | PubMed |
| Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer's Disease. | Int J Mol Sci | 2024 | 38473892 | PubTator, text mining | PubMed |
| Systemic proteome adaptions to 7-day complete caloric restriction in humans. | Nat Metab | 2024 | 38429390 | PubTator, text mining | PubMed |
| A strategy for boosting photovoltaic performance based on a two-dimensional ZrSSe/HfSSe van der Waals heterostructure. | Phys Chem Chem Phys | 2024 | 38412426 | PubTator, text mining | PubMed |
| Exploring the potential of EphA2 receptor signaling pathway: a comprehensive review in cancer treatment. | Mol Biol Rep | 2024 | 38393520 | PubTator, text mining | PubMed |
| Single cell atlas of human gastric muscle immune cells and macrophage-driven changes in idiopathic gastroparesis. | iScience | 2024 | 38384852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=5